CUBE vs UTHR · P/E 25, rev $1.07B vs P/E 20, rev $2.88B
CubeSmart (CUBE) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CUBE and UTHR stock pages for the full models.
Not investment advice.